Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey Study

Journal of Renal Nutrition

Volumn 26, Issue 6, 2016, Pages 373-379

  Arinsoy, Turgay ^a   Deger, Serpil Muge ^a   Ates, Kenan ^b   Altun, Bulent ^c   Ecder, Tevfik ^d   Camsari, Taner ^e   Serdengecti, Kamil ^f   Suleymanlar, Gultekin ^g  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e DOKUZ EYLUL UNIVERSITY   (Turkey)

^f ISTANBUL UNIVERSITY   (Turkey)

^g AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHRONIC KIDNEY FAILURE; COMPLICATION; GLOMERULUS FILTRATION RATE; HUMAN; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTOR;

ADULT; GLOMERULAR FILTRATION RATE; HUMANS; METABOLIC SYNDROME; OBESITY; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TURKEY;

EID: 84994748452     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2016.08.004     Document Type: Article

References (30)

1. 1 Yu, Z., Han, S., Chu, J., Xu, Z., Zhu, C., Guo, X., Trends in overweight and obesity among children and adolescents in China from 1981 to 2010: a meta-analysis. PLoS One, 7, 2012, e51949.
2. 2 Gupta, R., Sharma, K.K., Gupta, A., et al. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5. J Assoc Physicians India 60 (2012), 11–16.
3. 3 Schmitt, A.C., Cardoso, M.R., Lopes, H., et al. Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil. Menopause 20 (2013), 470–476.
4. 4 Satman, I., Yilmaz, T., Sengul, A., et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25 (2002), 1551–1556.
5. 5 Satman, I., Omer, B., Tutuncu, Y., et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28 (2013), 169–180.
6. 6 Obermayr, R.P., Temml, C., Knechtelsdorfer, M., et al. Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transpl 23 (2008), 1265–1273.
7. 7 Wang, Y., Chen, X., Song, Y., Caballero, B., Cheskin, L.J., Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73 (2008), 19–33.
8. 8 Stengel, B., Tarver-Carr, M.E., Powe, N.R., Eberhardt, M.S., Brancati, F.L., Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 14 (2003), 479–487.
9. 9 Onat, A., Hergenc, G., Can, G., [Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition]. Anadolu Kardiyol Derg 7 (2007), 29–34.
10. 10 Yumuk, V.D., Prevalence of obesity in Turkey. Obes Rev 6 (2005), 9–10.
11. 11 Chen, J., Muntner, P., Hamm, L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004), 167–174.
12. 12 Suleymanlar, G., Utas, C., Arinsoy, T., et al. A population-based survey of Chronic REnal Disease In Turkey–the CREDIT study. Nephrol Dial Transpl 26 (2011), 1862–1871.
13. 13 Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N., Roth, D., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999), 461–470.
14. 14 Gansevoort, R.T., Verhave, J.C., Hillege, H.L., et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 94 (2005), S28–S35.
15. 15 Nishida, C., Ko, G.T., Kumanyika, S., Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 64 (2010), 2–5.
16. 16 Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21 (2006), 1–6.
17. 17 Ogden, C.L., Yanovski, S.Z., Carroll, M.D., Flegal, K.M., The Epidemiology of Obesity. Gastroenterology 132 (2007), 2087–2102.
18. 18 Tozawa, M., Iseki, K., Iseki, C., Oshiro, S., Ikemiya, Y., Takishita, S., Influence of smoking and obesity on the development of proteinuria. Kidney Int 62 (2002), 956–962.
19. 19 Kramer, H., Luke, A., Bidani, A., Cao, G., Cooper, R., McGee, D., Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 46 (2005), 587–594.
20. 20 Hsu, C.Y., McCulloch, C.E., Iribarren, C., Darbinian, J., Go, A.S., Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006), 21–28.
21. 21 Satirapoj, B., Supasyndh, O., Mayteedol, N., et al. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives. Nephrology (Carlton) 18 (2013), 229–234.
22. 22 Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., Takishita, S., Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 (2004), 1870–1876.
23. 23 Fox, C.S., Larson, M.G., Leip, E.P., Culleton, B., Wilson, P.W., Levy, D., Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004), 844–850.
24. 24 Thomas, G., Sehgal, A.R., Kashyap, S.R., Srinivas, T.R., Kirwan, J.P., Navaneethan, S.D., Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6 (2011), 2364–2373.
25. 25 Kurella, M., Lo, J.C., Chertow, G.M., Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005), 2134–2140.
26. 26 Wickman, C., Kramer, H., Obesity and kidney disease: potential mechanisms. Semin Nephrol 33 (2013), 14–22.
27. 27 Sarafidis, P.A., Lasaridis, A.N., Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?. J Cardiometab Syndr 3 (2008), 183–187.
28. 28 Sarafidis, P.A., Ruilope, L.M., Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26 (2006), 232–244.
29. 29 Tesauro, M., Canale, M.P., Rodia, G., et al. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract, 2011, 2011, 653182.
30. 30 Stenvinkel, P., Zoccali, C., Ikizler, T.A., Obesity in CKD–What Should Nephrologists Know?. J Am Soc Nephrol 24 (2013), 1727–1736.